1Randolph G W. Surgery of Thyroid and Parathyroid Glands[J]. Elsevier Science, 2003, 78: 9.
2Mazzaferri E L. NCCN Thyroid Carcinoma Practice Guidelines[J]. Oncology, 1999, 13: 391.
3Hundahl S A, Fleming I D, Fremgen A M, et al. A National Cancer Data Base Report on 53, 856 cases of thyroid carcinoma treated in the United States, 1985～1995[J]. Cancer, 1998, 83: 2638.
4Grebe S K, Hay I D. Follicular cell-derived thyroid carcinomas[J]. Cancer Treat Res, 1997, 89: 91.
5Hay I D, Grant C S, Taylor W F, et al. Ipsilateral lobectomy vs bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system[J]. Surgery, 1987, 102: 1088.
6Hay I D, Grant C S, Bergstralh E J, et al. Unilateral thyroidectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma[J]. Surgery, 1998, 124: 958.
7Grant C S, Hay I D, Bergstralh E J, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important[J]. Surgery, 1988, 104: 594.
8Hay I D, Bergstralh E J, Grant C S, et al. Impact of primary surgery on outcome in 300 patients with pathological tumornode-metastasis stage Ⅲ papillary thyroid carcinoma treated at one institution from 1940 through 1989[J]. Surgery, 1999, 126: 1173.
9Grebe S K G, Hay I D. The role of surgery in the management of differentiated thyroid cancer[J]. J endocrinal invest, 1997, 20: 32.
10Cady B. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer[J]. Am J Surg, 1997, 174: 462.
